Awardees include Apple Inc. for breakthroughs in accessible technology, actor Charlie Cox for his portrayal of a blind superhero, Ward Marston a musician/recording engineer with vision loss, and Vanda Pharmaceuticals Inc. for pioneering treatment of a circadian rhythm disorder, Non-24 Sleep-Wake Disorder, that can affect people who are totally blind.
“We are honoring accomplished individuals and companies for their success in improving quality of life for people with vision loss either through groundbreaking innovation or inspirational achievement that changes perceptions about what it means to be visually impaired,” said AFB President & CEO Carl R. Augusto, in a statement.
AFB is recognizing Apple for VoiceOver, a gesture-based screen reader that allows users to hear a description of everything happening on the display, and other features that make iPhone, iPad and other iOS devices accessible to people with vision loss. Apple received an AFB Access Award in 2009 for its trailblazing engineering of accessible products and continues its extraordinary efforts to make their products accessible for everyone.
Charlie Cox, a British actor who has appeared in major UK and US television and film productions, is being honored for introducing a new generation of audiences to the iconic Marvel character Matt Murdock in Marvel’s Daredevil, a new original series on Netflix. After being exposed to radioactive material as a child, Murdock went blind but found that the accident also granted him heightened senses. Along with his special training, Murdock uses his special abilities to fight crime in modern day Hell’s Kitchen, New York.
Musician and band leader Ward Marston is being recognized for a distinguished career both as a performer and musical historian and preservationist. He has re-mastered hundreds of classical recordings and jammed with the likes of Count Basie traveling widely with the Ward Marston Orchestra and performing at major events and venues across the country.
Vanda Pharmaceuticals Inc. is being recognized for scientific innovation in developing the first and only FDA approved treatment for people who are totally blind and living with Non-24. Non-24 is a disorder that disrupts the body’s internal clock and can lead to sleep challenges, especially for people with total blindness. This is primarily due to the lack of light perception needed to keep a body’s internal rhythm in sync with a 24-hour day.
AFB’s Helen Keller Achievement Awards gala will bring together leaders from business, education, government, the arts and entertainment. It will take place on Thursday evening, June 18, 2015 at the J.W. Marriott Essex House New York, 160 Central Park South.
Source: The American Foundation for the Blind (AFB)